In About-Face, Gene Logic Plans to Sell Preclinical Business | GenomeWeb
NEW YORK (GenomeWeb News) — Gene Logic today said it plans to sell its preclinical services business, has hired an investment bank to help with this goal, and is already talking with a possible buyer.
The decision is a departure for Gene Logic, which during a restructuring announced in September said the preclinical business will remain with the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.